Ftse Mib
34.532,76
-0,20%
DAX
18.685,20
-0,22%
S&P 500
5.321,41
0,00%
NASDAQ
16.832,62
0,00%
Bitcoin
69.872,73
-0,37%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Pandion Therapeutics Inc (PAND) Pandion Therapeutics Inc (PAND) Notizie

PAND

Pandion Therapeutics (PAND)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PAND
DataOraFonteTitoloSimboloCompagnia
17/05/202122:40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PANDPandion Therapeutics Inc
12/04/202112:55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PANDPandion Therapeutics Inc
08/04/202123:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PANDPandion Therapeutics Inc
06/04/202112:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PANDPandion Therapeutics Inc
02/04/202101:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114:47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114:44Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114:38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114:26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PANDPandion Therapeutics Inc
31/03/202122:03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PANDPandion Therapeutics Inc
12/03/202123:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PANDPandion Therapeutics Inc
04/03/202123:16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PANDPandion Therapeutics Inc
04/03/202122:49Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PANDPandion Therapeutics Inc
04/03/202122:35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PANDPandion Therapeutics Inc
26/02/202122:59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PANDPandion Therapeutics Inc
26/02/202107:26TipRanksMerck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares SkyrocketNASDAQ:PANDPandion Therapeutics Inc
25/02/202122:02Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PANDPandion Therapeutics Inc
25/02/202115:28Dow Jones NewsPandion Shares More Than Double Premarket on Takeover by MerckNASDAQ:PANDPandion Therapeutics Inc
25/02/202114:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PANDPandion Therapeutics Inc
25/02/202113:28Dow Jones NewsMerck to Buy Pandion Therapeutics for $1.85 BillionNASDAQ:PANDPandion Therapeutics Inc
25/02/202112:45Business WireMerck to Acquire Pandion TherapeuticsNASDAQ:PANDPandion Therapeutics Inc
22/02/202114:30GlobeNewswire Inc.Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoi...NASDAQ:PANDPandion Therapeutics Inc
18/02/202114:30GlobeNewswire Inc.Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
16/02/202122:52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PANDPandion Therapeutics Inc
04/01/202114:00GlobeNewswire Inc.Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expa...NASDAQ:PANDPandion Therapeutics Inc
03/12/202014:00GlobeNewswire Inc.Pandion Therapeutics Appoints Katina Dorton to its Board of DirectorsNASDAQ:PANDPandion Therapeutics Inc
16/11/202022:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PANDPandion Therapeutics Inc
16/11/202022:01GlobeNewswire Inc.Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:PANDPandion Therapeutics Inc
10/11/202014:00GlobeNewswire Inc.Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PAND

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STMMI
ST Microelectronics
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network